Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a body”

255 pharma patents match "The Regents of the University of Colorado, a body" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 255
Index total 30,257
Page 7 / 11

Quick answer

This filtered view shows 255 pharmaceutical patents matching "The Regents of the University of Colorado, a body" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

255 results for “The Regents of the University of Colorado, a body” · 30,257 patents in full index Clear search

  1. US 9895420

    IL-1beta propeptide and IL-1Ra chimera and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  2. US 9884096

    Compositions and methods related to graft versus host disease and treatments thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  3. US 9885018

    High efficiency reprogramming of fibroblasts into cardiomyocytes

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  4. US 9840520

    Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  5. US 9820957

    Methods of treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  6. US 9820951

    Pulmonary disease treatment and diagnosis based on Arhgef1

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  7. US 9815890

    Antibodies to the C3d fragment of complement component 3

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  8. US 9775876

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  9. US 9759731

    Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  10. US 9701713

    Compositions and methods for introduction of macromolecules into cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  11. US 9700492

    Dental composites systems and methods of making the same and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  12. US 9701792

    Composite compositions and methods of preparing and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  13. US 9700628

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  14. US 9695229

    Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  15. US 9687527

    Stable glucagon formulations for the treatment of hypoglycemia

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  16. US 9683025

    Methods and compositions for treating cancer and inflammatory diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  17. US 9675678

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  18. US 9650447

    Complement receptor 2 (CR2) targeting groups

    The Regents of the University of Colorado, a Body Corporate · Granted May 16, 2017 · Expires May 11, 2037

    granted

  19. US 9639665

    Methods for diagnosis and intervention of hepatic disorders

    The Regents of the University of Colorado, a Body Corporate · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

  20. US 9631188

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  21. US 9629848

    Compounds that modulate autoimmunity and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  22. US 9603829

    HSP90 inhibitors with modified toxicity

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  23. US 9562015

    Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations

    The Regents of the University of Colorado, a body · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  24. US 9562088

    Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.